)
Ortoma (ORT) investor relations material
Ortoma Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Achieved record sales of 21 systems in Q2 2026, totaling 36 systems for H1, surpassing full-year 2025 sales.
Largest order in company history received post-period, valued at 32 MSEK for Europe, USA, and Japan.
Focused on disciplined execution of commercialization plan for OTS™ Hip, with ongoing international rollout.
Strengthened financial position through successful rights and directed issues, raising approximately 68 MSEK before costs.
Financial highlights
Q2 2026 net revenue: 10.4 MSEK (vs. 18.8 MSEK Q2 2025); H1 2026 net revenue: 26.2 MSEK (vs. 57.5 MSEK H1 2025).
Q2 2026 EBITDA: -18.1 MSEK (vs. 4.5 MSEK Q2 2025); H1 2026 EBITDA: -22.8 MSEK (vs. 24.1 MSEK H1 2025).
Q2 2026 net result: -21.1 MSEK (vs. 1.3 MSEK Q2 2025); H1 2026 net result: -29.2 MSEK (vs. 17.6 MSEK H1 2025).
Cash flow from operations H1 2026: -18.6 MSEK (vs. 34.1 MSEK H1 2025); cash at period end: 62.7 MSEK.
Equity ratio at period end: 88.7% (vs. 91.6% prior year).
Outlook and guidance
Order book and revenues now total approximately 60 MSEK, below the previously communicated 80 MSEK full-year target.
Management acknowledges difficulty in reaching the 80 MSEK target but continues efforts to achieve it.
2026 goal: 100 systems sold and 80 MSEK in operating revenue, including 10 MSEK in milestone payments.
Ambition for positive cash flow in H2 2027 and revenue exceeding 220 MSEK in 2028.
- Commercial focus, regulatory wins, and strengthened finances despite lower Q1 revenue.ORT
Q1 202621 May 2026 - 2025 saw higher sales from milestones, ongoing losses, and global expansion of OTS™ Hip.ORT
Q4 202526 Feb 2026 - YTD revenue and profit improved, with regulatory and commercial progress in key markets.ORT
Q3 20255 Nov 2025 - FDA approval and milestone payment fueled record sales and profit growth in H1 2025.ORT
Q2 202530 Jul 2025 - Record US order and strong Q3 sales drive Ortoma's positive momentum.ORT
Q3 202413 Jun 2025 - Milestone-driven revenue growth offset by lower earnings as Ortoma invests in commercialization.ORT
Q2 202413 Jun 2025 - Record revenue, regulatory wins, and 400+ implantations fuel profitable growth.ORT
Q1 20259 Jun 2025 - Revenue up, EBITDA positive, and US commercialization underway pending approvals.ORT
Q4 20245 Jun 2025
Next Ortoma earnings date
Next Ortoma earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)